Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271628 | 0.81 | MAPT (0.41) | MAPTL3MBTL1MEN1POLBGAA | |
| SCHEMBL3158626 | 0.75 | CHUK (0.36) | MAPTCHUKDHFR | |
| SCHEMBL6356983 | 0.75 | CHUK (0.36) | MAPTCSNK2A1CSNK2A2CSNK2BKDM4E | |
| SCHEMBL6358280 | 0.72 | CSNK2A1 (0.36) | L3MBTL1PARP1CSNK2A1KDM4EHTT | |
| SCHEMBL6358729 | 0.71 | DPP4 (0.43) | MAPTL3MBTL1MEN1POLBGAA | |
| SCHEMBL1270582 | 0.71 | KDM4E (0.49) | MAPTL3MBTL1MEN1POLBGAA | |
| SCHEMBL3651176 | 0.69 | HSD17B10 (0.39) | MAPTL3MBTL1MEN1POLBGAA | |
| SCHEMBL6363420 | 0.68 | CHUK (0.32) | MAPTL3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20092266 | 0.68 | HSD17B10 (0.40) | MAPTL3MBTL1MEN1POLBGAA | |
| SCHEMBL31124736 | 0.66 | L3MBTL1 (0.35) | MAPTL3MBTL1MEN1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1923171-B | Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof | JINAN KANGQUAN PHARMACEUTICAL CO LTD | 2010-05-19 | — | — | CN | disclosed |
| CN-100563710-C | The anticancer medicine slow-release preparation containing that contains pyrimidine analogue | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2009-12-02 | — | — | CN | disclosed |
| CN-100500215-C | Sustained-release injection containing methotrexate and synergist thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2009-06-17 | — | — | CN | disclosed |
| CN-101380306-A | Compound platinum medicine sustained-release agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2009-03-11 | — | — | CN | disclosed |
| CN-101380297-A | Compound platinum medicine sustained-release agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2009-03-11 | — | — | CN | disclosed |
| CN-101292956-A | Sustained-release injection containing methotrexate and its synergistic agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| CN-101292955-A | Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| CN-101244033-A | Sustained-release agent containing taxone and its synergistic agent | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-08-20 | — | — | CN | disclosed |
| CN-101244034-A | Sustained-release agent containing taxone and its synergistic agent | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-08-20 | — | — | CN | disclosed |
| CN-100386115-C | Anti-cancer medicine composition | QINGZHONG KONG (CN) | 2008-05-07 | — | — | CN | disclosed |
| EP-0775142-B1 | SUBSTITUTED O6 -BENZYLGUANINES | US HEALTH (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6303604-B1 | USED AS ANTINEOPLASTIC ALKYLATING AGENT WHICH CAUSES CYTOTOXIC LESIONS AT THE O.SUP.6-POSITION OF QUANINE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-10-16 | — | — | US | disclosed |
| EP-1142893-A1 | Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6172070-B1 | IN POLYOXYETHYLENE GLYCOL CARRIER | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-01-09 | — | — | US | disclosed |
| US-5958932-A | ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-09-28 | — | — | US | disclosed |
| US-5916894-A | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-06-29 | — | — | US | disclosed |
| US-5753668-A | Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0775142-A1 | SUBSTITUTED O6 -BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5525606-A | CHEMOTHERAPEUTIC ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1996004281-A1 | SUBSTITUTED O6-BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-15 | — | — | WO | disclosed |